Approach to the diagnosis and management of tuberculous meningitis

Current Infectious Disease Reports

Volumn 12, Issue 4, 2010, Pages 291-298

  Sinner, Scott W ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ID Care   (United States)

Author keywords

Corticosteroid therapy; Extrapulmonary tuberculosis; Hydrocephalus; Mycobacterium tuberculosis; Polymerase chain reaction; Tuberculous meningitis

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; CYCLOSERINE; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; HYDROCORTISONE; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; PREDNISOLONE; PREDNISONE; PYRAZINAMIDE; PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ADD ON THERAPY; AREA UNDER THE CURVE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG PENETRATION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; LABORATORY DIAGNOSIS; LIVER TOXICITY; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEUROSURGERY; NEUROTOXICITY; NUCLEIC ACID AMPLIFICATION; OPTIC NEURITIS; POLYMERASE CHAIN REACTION; RADIOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULOUS MENINGITIS;

EID: 77956267095     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0106-3     Document Type: Review

References (50)

1. Zuger A: Tuberculosis. In Infections of the Central Nervous System, edn 3. Edited by Scheld WM, Whitley RJ, Marra CM. Philadelphia: Lippincott Williams & Wilkins; 2004:441-460.
2. Tunkel AR: Bacterial Meningitis. Philadelphia: Lippincott Williams & Wilkins; 2001.
3. Fitzgerald DW, Sterling TR, Haas DW: Mycobacterium tuberculosis. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, edn 7. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone; 2010:3129-3163.
4. SM Katrak PK Shembalkar SR Bijwe LD Bhandarkar 2000 The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection J Neurol Sci 181 118 126 10.1016/S0022-510X(00)00440-8 1:STN:280:DC%2BD3M%2FpvVaqsw%3D%3D 11099721
5. ME Torok TT Chau PP Mai, et al. 2008 Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults PLoS ONE 3 e1772 10.1371/journal.pone.0001772 18350135
6. EK Tan MWL Chee LL Chan YL Lee 1999 Culture positive tuberculous meningitis: clinical indicators of poor prognosis Clin Neurol Neurosurg 101 157 160 10.1016/S0303-8467(99)00025-6 1:STN:280:DC%2BD3c%2FgsFaqsA%3D%3D 10536900
7. R Kumar SN Singh N Kohli 1999 A diagnostic rule for tuberculous meningitis Arch Dis Child 81 221 224 10.1136/adc.81.3.221 1:STN:280: DyaK1MvitFGntA%3D%3D 10451394
8. R Mihailescu A Hristea C Baicus, et al. 2007 Predictors of tuberculosis in acute aseptic meningitis syndrome Rom J Intern Med 45 379 385 18767414
9. GT van Well BF Paes CB Terwee, et al. 2009 Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa Pediatrics 123 e1 e8 10.1542/peds.2008-1353 19367678 This paper reports on the largest pediatric cohort of TBM patients (554) yet published. Ethnicity, stage of disease, headache, convulsions, motor function, brainstem dysfunction, and cerebral infarctions were independently associated with poor clinical outcome. Stage II and III disease were very common, as were poor weight gain (or frank weight loss), loss of consciousness, and hydrocephalus. At 6 months, mortality was 13%, and only 16% of children were clinically normal at follow-up
10. S Hosoglu MF Geyik I Balik, et al. 2002 Predictors of outcome in patients with tuberculous meningitis Int J Tubercul Lung Dis 6 64 70 1:STN:280:DC%2BD387pvVyitQ%3D%3D
11. KH Chan RT Cheung CY Fong, et al. 2003 Clinical relevance of hydrocephalus as a presenting feature of tuberculous meningitis Q J Med 96 643 648 1:STN:280:DC%2BD3szovVyrug%3D%3D
12. J Kalita UK Misra PP Nair 2009 Predictors of stroke and its significance in the outcome of tuberculous meningitis J Stroke Cerebrovasc Dis 18 251 258 10.1016/j.jstrokecerebrovasdis.2008.11.007 19560677
13. A Yaramis Y Bukte S Katar MN Ozbek 2007 Chest computerized tomography scan findings in 74 children with tuberculous meningitis in southeastern Turkey Turk J Pediatr 49 365 369 18246736
14. M Piepaar S Andronikou R van Toorn 2009 MRI to demonstrate diagnostic features and complications of TBM not seen with CT Childs Nerv Syst 25 941 947 10.1007/s00381-008-0785-3
15. VL Pinto Jr MA Lima VC Rolla, et al. 2009 Atypical cerebrospinal fluid profile in tuberculous meningitis Trop Doct 39 76 78 10.1258/td.2008.080242 19299285
16. VB Patel I Burger C Connolly 2008 Temporal evolution of cerebrospinal fluid following initiation of treatment for tuberculous meningitis S Afr Med J 98 610 613 1:STN:280:DC%2BD1cnntFektQ%3D%3D 18928039 Prior to this publication, changes in CSF following the initiation of antituberculous treatment had not been well described. The rapid changes in neutrophil count and glucose concentration on repeat CSF samples of 99 patients with TBM seemed to assist clinicians in making decisions about patient care in the early phase of treatment, in contrast to the slow changes in lymphocyte count and protein concentration. It was believed to be very atypical for TBM for a repeat lumbar puncture (at 4-8 weeks) not to show definite improvement in neutrophil count and glucose concentration
17. MM Venkataswamy W Rafi S Nagarathna, et al. 2007 Comparative evaluation of BACTEC 460TB system and Lowenstein-Jensen medium for the isolation of M. tuberculosis from cerebrospinal fluid samples of tuberculous meningitis patients Indian J Med Microbiol 25 236 240 10.4103/0255-0857.34765 1:STN:280: DC%2BD2srnvV2nsw%3D%3D 17901641
18. M Caws TM Dang E Torok, et al. 2007 Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis PLoS ONE 2 e1173 10.1371/journal.pone.0001173 18000545 These investigators showed the MODS culture technique to be nearly as sensitive as mycobacterial growth indicator tube (MGIT) and Lowenstein-Jensen (LJ) cultures for the diagnosis of TBM (65% sensitivity for MODS vs 70% sensitivity for the other two methods, using clinical diagnosis as the gold standard). The great advantages to the MODS technique were a mean time to positive culture of 6 days (vs 15.5 days for MGIT and 24 days for LJ cultures), a very low cost per sample (once an inverted microscope is purchased), and the ability to have susceptibility results as soon as cultures are positive
19. I Corral C Quereda E Navas, et al. 2004 Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis Eur J Clin Microbiol Infect Dis 23 471 476 10.1007/s10096-004-1110-z 1:CAS:528:DC%2BD2cXks1Kmtbc%3D 15141333
20. W Rafi MM Venkataswamy S Nagarathna, et al. 2007 Role of IS6110 uniplex PCR in the diagnosis of tuberculous meningitis: experience at a tertiary neurocentre Int J Tubercul Lung Dis 11 209 214 1:STN:280: DC%2BD2s%2FlvFWmtw%3D%3D
21. T Takahashi M Tamura Y Asami, et al. 2008 Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis J Clin Microbiol 46 1698 1707 10.1128/JCM.02214-07 1:CAS:528:DC%2BD1cXmvV2msbk%3D 18337387 The use of PCR in the diagnosis of TBM has had much promise, but not nearly as much clinical success up to this point. However, advances are constantly being made. This paper describes a new PCR technique that combines the high sensitivity of nested PCR, the accurate quantification of real-time PCR, and a wide detection range for number of copies of DNA in CSF samples. The clinical usefulness of this exciting technique remains to be determined
22. HJ Huang DR Xiang JF Sheng, et al. 2009 rpoB nested PCR and sequencing for the early diagnosis of tuberculous meningitis and rifampicin resistance Int J Tubercul Lung Dis 13 749 754
23. S Haldar N Sharma VK Gupta JS Tyagi 2009 Efficient diagnosis of tuberculous meningitis by detection of Mycobacterium tuberculosis DNA in cerebrospinal fluid filtrates using PCR J Med Microbiol 58 Pt 5 616 624 10.1099/jmm.0.006015-0 1:CAS:528:DC%2BD1MXmt1WksL8%3D 19369523
24. GE Thwaites M Caws TT Chau, et al. 2004 Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy J Clin Microbiol 42 996 1002 10.1128/JCM.42.3.996- 1002.2004 1:CAS:528:DC%2BD2cXivF2ksLo%3D 15004044
25. A Chandramuki K Lyashchenko HB Kumari, et al. 2002 Detection of antibody to Mycobacterium tuberculosis protein antigens in the cerebrospinal fluid of patients with tuberculous meningitis J Infect Dis 186 678 683 10.1086/342293 1:CAS:528:DC%2BD38XnsVSlurw%3D 12195355
26. RS Kashyap NP Agarwal NH Chandak, et al. 2002 The application of the Mancini technique as a diagnostic test in the CSF of tuberculous meningitis patients Med Sci Monit 8 MT95 MT98 12070446
27. RS Kashyap RP Kainthla SK Biswas, et al. 2003 Rapid diagnosis of tuberculous meningitis using the Simple Dot ELISA method Med Sci Monit 9 MT123 MT126 14586287
28. A Mathai VV Radhakrishnan C Sarada SM George 2003 Detection of heat stable mycobacterial antigen in cerebrospinal fluid by Dot-Immunobinding assay Neurol India 51 52 54 1:STN:280:DC%2BD3szjtlClsw%3D%3D 12865516
29. C Quan CZ Lu J Qiao, et al. 2006 Comparative evaluation of early diagnosis of tuberculous meningitis by different assays J Clin Microbiol 44 3160 3166 10.1128/JCM.00333-06 16954242
30. JW Alffenaar R van Altena HJ Bokkerink, et al. 2009 Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis Clin Infect Dis 49 1080 1082 10.1086/605576 1:CAS:528: DC%2BD1MXhtlehs7rO 19712035 It has been almost 50 years since the introduction of a new first-line antimicrobial agent for the treatment of tuberculosis. Of currently available drugs, the new fluoroquinolones have the most promise. Moxifloxacin has the greatest in vitro activity against M. tuberculosis, and though published clinical data on its use in TBM are limited, this report is encouraging with regard to thinking about moxifloxacin as a reasonable second-line agent for TBM
31. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America 2003 Treatment of tuberculosis Am J Respir Crit Care Med 167 603 662 10.1164/rccm.167.4.603
32. SE Berning TA Cherry MD Iseman 2001 Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report Clin Infect Dis 32 643 646 10.1086/318698 1:STN:280:DC%2BD3MvkslWmsA%3D%3D 11181130
33. T Takahashi K Ogawa S Sawada, et al. 2003 A case of refractory tuberculous meningitis markedly improved by intrathecal administration of isoniazid (INH) [Japanese] Rinsho Shinkeigaku Clin Neurol 43 20 25
34. R Kumar M Prakash S Jha 2006 Paradoxical response to chemotherapy in neurotuberculosis Pediatr Neurosurg 42 214 222 10.1159/000092357 16714861
35. M Ashby H Grant 1955 Tuberculous meningitis treated with cortisone Lancet 1 65 66 10.1016/S0140-6736(55)90003-9
36. BF Voljavec RF Corpe 1960 The influence of corticosteroid hormones in the treatment of tuberculous meningitis in Negroes Am Rev Respir Dis 81 539 545 1:CAS:528:DyaF3MXmtVOlug%3D%3D
37. MH Lepper HW Spies 1963 The present status of the treatment of tuberculosis of the central nervous system Ann NY Acad Sci 106 106 123 10.1111/j.1749-6632.1963.tb16629.x 1:STN:280:DyaF387itFCmtg%3D%3D 13929802
38. RD O'Toole GF Thornton MK Mukherjee RL Nath 1969 Dexamethasone in tuberculous meningitis: relationship of cerebrospinal fluid effects to therapeutic efficacy Ann Intern Med 70 39 48 5304225
39. JA Escobar MA Belsey A Duenes P Medina 1975 Mortality from tuberculous meningitis reduced by steroid therapy Pediatrics 56 1050 1055 1:STN:280:DyaE28%2Fns12mtA%3D%3D 1105378
40. NI Girgis Z Farid LS Hanna, et al. 1983 The use of dexamethasone in preventing ocular complications in tuberculous meningitis Trans R Soc Trop Med Hyg 77 658 659 10.1016/0035-9203(83)90195-5 1:STN:280:DyaL2c%2FpvV2nsw%3D%3D 6659045
41. NI Girgis Z Farid ME Kilpatrick, et al. 1991 Dexamethasone adjunctive treatment for tuberculous meningitis Pediatr Infect Dis J 10 179 183 10.1097/00006454-199103000-00002 1:STN:280:DyaK3M3lt1Wjsg%3D%3D 2041662
42. S Kumarvelu K Prasad A Khosla, et al. 1994 Randomized controlled trial of dexamethasone in tuberculous meningitis Tubercle Lung Dis 75 302 307 10.1016/0962-8479(94)90009-4
43. V Chotmongkol S Jitpimolmard Y Thavornpitak 1996 Corticosteroid in tuberculous meningitis J Med Assoc Thai 79 83 90 1:STN:280: DyaK2s%2FitFKmug%3D%3D 8868018
44. JF Schoeman LE Van Zyl JA Laubscher PR Donald 1997 Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcomes in young children with tuberculous meningitis Pediatrics 99 226 231 10.1542/peds.99.2.226 1:STN:280:DyaK2s7ns12isA%3D%3D 9024451
45. DV Lardizabal AA Roxas 1998 Dexamethasone as adjunctive therapy in adult patients with probable TB meningitis stage II and stage III: an open randomised controlled trial Philipp J Neurol 4 4 10
46. GE Thwaites DB Nguyen HD Nguyen, et al. 2004 Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults New Engl J Med 351 1741 1751 10.1056/NEJMoa040573 1:CAS:528:DC%2BD2cXovFSktrY%3D 15496623
47. K Prasad MB Singh 2008 Corticosteroids for managing tuberculous meningitis Cochrane Database Syst Rev 1 CD002244 18254003 This systematic review examined seven randomized controlled trials (1140 patients) of adjunctive corticosteroids in TBM, and noted a significant improvement in mortality rate with steroid therapy. In the three trials that studied the composite endpoint of death or disabling residual neurologic deficit, a significant improvement was noted. The authors recommended dexamethasone or prednisolone for HIV-negative children (3-6 weeks of therapy) and adults (6 weeks of therapy) to reduce death and disabling residual neurologic deficit among survivors
48. D Singh V Sachdev AK Singh S Sinha 2005 Endoscopic third ventriculostomy in post-tubercular meningitic hydrocephalus: a preliminary report Minim Invasive Neurosurg 48 47 52 10.1055/s-2004-830183 1:STN:280:DC%2BD2M7hs1SqsA%3D%3D 15747217
49. SK Das D Ghosh A Singhi, et al. 2007 Dural biopsy-an important prognostic indicator in tuberculous meningitis with hydrocephalus following shunt surgery J Indian Med Assoc 105 12 15 17802970
50. JJ Kelly EA Horowitz CJ Destache, et al. 1999 Diagnosis and treatment of complicated tubercular meningitis Pharmacotherapy 19 1167 1172 10.1592/phco.19.15.1167.30575 1:STN:280:DyaK1MvktVKitQ%3D%3D 10512066